PepperLime Health Acquisition Corporation Unit
PEPLU
PEPLU was delisted on the 19th of January, 2024.
11 hedge funds and large institutions have $15.1M invested in PepperLime Health Acquisition Corporation Unit in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 5 closing their positions.
27% less funds holding
Funds holding: 15 → 11 (-4)
33% less capital invested
Capital invested by funds: $22.6M → $15.1M (-$7.47M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$106K |
Top Sellers
PEPLU Hedge Fund Activity: Q3 2022 in Review
11 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in PepperLime Health Acquisition Corporation Unit (PEPLU) for Q3 2022, worth a combined $15.1M — down 33% from $22.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PEPLU and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 0 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $106K. The largest seller was Calamos Advisors, exiting entirely with an estimated $6.96M sold.
- 11 institutional investors held PepperLime Health Acquisition Corporation Unit (PEPLU) as of Q3 2022, down from 15 in Q2 2022.
- Funds reported $15.1M of PepperLime Health Acquisition Corporation Unit stock for Q3 2022, down 33% quarter-over-quarter.
- 1 fund opened new PepperLime Health Acquisition Corporation Unit positions in Q3 2022 and 5 closed out, a net change of -4 holders.
- The largest PepperLime Health Acquisition Corporation Unit buyer in Q3 2022 was Susquehanna International Group, an estimated $106K added.
- The largest PepperLime Health Acquisition Corporation Unit seller in Q3 2022 was Calamos Advisors, an estimated $6.96M sold.
Based on aggregated 13F filings for Q3 2022.